Financial News Feed

Stronger Sell Today TYME ranks #3440 as SELL CANDIDATE. Weaker Sell
Today TYME ranks #3440 as SELL CANDIDATE.

TYME stock Tyme Technologies Inc

TYME stock
Tyme Technologies Inc

Both Tyme Technologies Inc. (NASDAQ:TYME) and Zymeworks Inc. (NYSE:ZYME) are each other’s competitor in the Biotechnology industry. Thus the contrast of their...

Read more

Tyme Technologies Inc. (NASDAQ:TYME) and Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR), are influenced by contrast since they are both players in the...

Read more

Major market players are buzzing over Tyme Technologies, Inc. (:TYME) as their share price hit $2.27 at the end of the most recent trading session. Outstanding shares are common stock authorized by a ...

Read more

Tyme Technologies Inc. (NASDAQ:TYME) and Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) are two firms in the Biotechnology that compete against each other. Below is a comparison of their risk, analyst reco...

Read more

This is therefore a comparing of the dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation in Tyme Technologies Inc. (NASDAQ:TYME) and Rhythm Pharmac...

Read more

We are comparing resTORbio Inc. (NASDAQ:TORC) and Tyme Technologies Inc. (NASDAQ:TYME) on their institutional ownership, profitability, risk, analyst...

Read more

Pulmatrix Inc. (NASDAQ:PULM) and Tyme Technologies Inc. (NASDAQ:TYME) compete with each other in the Biotechnology sector. We will analyze and compare their profitability, institutional ownership, ana...

Read more

Here we will take a look at several key ratios for PIOLAX, Inc. (TSE:5988), starting with the Book to Market (BTM) ratio. Value investors seek stocks with high BTMs for their portfolios. The ratio is ...

Read more

This is therefore a contrasting of the profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation in Minerva Neurosciences Inc. (NASDAQ:NERV) and Tyme Tec...

Read more

This is therefore a comparing of the dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership in Tyme Technologies Inc. (NASDAQ:TYME) and Anchiano Thera...

Read more

This is therefore a comparing of the dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation in CytRx...

Read more

We are comparing Novavax Inc. (NASDAQ:NVAX) and Tyme Technologies Inc. (NASDAQ:TYME) on their profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership. ...

Read more

Tyme Technologies Inc. (NASDAQ:TYME) and Prana Biotechnology Limited (NASDAQ:PRAN) are two firms in the Biotechnology that compete against each other. Below is a comparison of their dividends, analyst...

Read more

Gemphire Therapeutics Inc. (NASDAQ:GEMP) and Tyme Technologies Inc. (NASDAQ:TYME) compete with each other in the Biotechnology sector. We will analyze and compare their dividends, analyst recommendati...

Read more

We are contrasting Therapix Biosciences Ltd. (NASDAQ:TRPX) and Tyme Technologies Inc. (NASDAQ:TYME) on their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings ...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank